Find clinical trials for Chronic Sinusitis. Search for Chronic Sinusitis clinical trials in different cities and states across the United States.
Chronic sinusitis, also known as chronic rhinosinusitis, is a persistent inflammation of the paranasal sinuses that lasts for more than 12 weeks. This condition often leads to constant nasal congestion, facial pressure, and headaches.
There are two primary forms: chronic rhinosinusitis with nasal polyps (CRSwNP) and chronic rhinosinusitis without nasal polyps (CRSsNP). Each form presents different challenges in treatment, but clinical trials are actively investigating new therapies for both.
Common symptoms include nasal congestion, sinus congestion, and difficulty breathing through the nose. Recurrent infections or a chronic sinus infection may also occur. Severe cases often lead to a severe sinus infection that may require specialized sinusitis inflammation treatment or surgery.
Effective chronic sinusitis treatment depends on the underlying cause. Bacterial rhinosinusitis may require antibiotics, while other forms can benefit from nasal sprays, corticosteroids, or surgery. Patients with chronic rhinosinusitis treatment needs may also explore newer therapies, including advanced treatments for polyposis sinusitis and chronic nasal congestion treatment.
Treating chronic sinusitis can be complex, especially for patients who don't respond well to traditional treatments like corticosteroids or surgery. Many patients continue to suffer from chronic nasal congestion, recurring sinus infections, and other debilitating symptoms. Finding the right chronic sinusitis treatment is often a process of trial and error.
However, participation in clinical trials opens the door to new treatment options, from targeted biologics to innovative therapies addressing chronic sinus congestion treatment and bacterial rhinosinusitis.
Current clinical trials focus on advanced therapies for managing chronic sinusitis and related conditions, such as constant nasal congestion and chronic sinus infection. Trials investigating biologics, such as Dupilumab, are exploring cutting-edge treatments for patients with severe sinus infection and chronic nasal congestion who haven't responded to standard therapies.
These trials also evaluate new medications targeting sinusitis inflammation treatment, providing alternative options to traditional steroids or surgery.
Biologic trials are exploring new treatment options for chronic sinusitis, particularly for patients with chronic rhinosinusitis with nasal polyps. These trials focus on biologic therapies that target specific pathways in the immune system, which play a crucial role in causing inflammation.
Unlike traditional treatments that may suppress the immune response broadly, biologics aim to directly address the underlying causes of inflammation. By doing so, they can potentially provide significant relief from symptoms such as nasal congestion, sinus pressure, and frequent infections.
Inflammation reduction studies are tackling chronic inflammation in the nasal passages, a key issue for patients with both chronic rhinosinusitis without nasal polyps and chronic rhinosinusitis with nasal polyps. These trials aim to develop targeted therapies that specifically reduce inflammation at its source.
Researchers are working on innovative approaches and medications designed to relieve symptoms like nasal obstruction, facial pain, and decreased sense of smell. The ultimate goal is to improve patients' overall well-being by minimizing the chronic inflammation that can lead to debilitating symptoms and recurrent infections.
Participating in a clinical trial for chronic sinusitis not only gives you access to the latest treatments but also helps advance medical research.
Clinical trials offer patients the opportunity to try new therapies that may not be available through traditional healthcare providers. If you suffer from chronic sinusitis disease or chronic sinus infection, these trials may help you find an alternative when other treatments have not worked.
Clinical trials often provide patients with specialized attention and care, ensuring that your symptoms of nasal congestion, chronic nasal congestion, or polyposis sinusitis are closely monitored.
By participating in trials, you contribute to the development of future therapies that could benefit others suffering from chronic sinusitis and related conditions like chronic rhinosinusitis treatment.
Interested in knowing more about the benefits of participating in a clinical trial? Read our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential benefits, risks, and safety considerations to make an informed decision about your participation in a clinical trial.
When joining a clinical trial for chronic sinusitis, participants can expect a clear and organized process. They will first go through a screening to see if they meet the eligibility criteria. If accepted, participants will receive information about the trial's goals, procedures, and any risks involved. Regular appointments will be scheduled to monitor symptoms, which may include tests and surveys. Throughout the trial, healthcare professionals will be available to provide support and answer questions.
If you’re suffering from chronic sinus infection, severe sinus infection, or experiencing chronic nasal congestion treatment challenges, you may qualify for one of the many clinical trials currently recruiting. Eligibility typically depends on your symptoms, previous treatments, and overall health. Trials may require that you have failed previous treatments or that your symptoms are severe enough to warrant experimental therapy.
Enrolling in a chronic sinusitis clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
Sponsor:
Insmed Incorporated
Location:
Code:
NCT06013241
Conditions
Chronic Rhinosinusitis Without Nasal Polyps
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Brensocatib
Placebo
Mometasone furoate nasal spray (MFNS)
Sponsor:
University of Alabama at Birmingham
Location:
Code:
NCT03439865
Conditions
Chronic Rhinosinusitis (Diagnosis)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ivacaftor
standard of care treatment
Sponsor:
Eli Lilly and Company
Location:
Code:
NCT06338995
Conditions
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
LY3650150
Placebo
Standard therapy for INCS
Sponsor:
Montefiore Medical Center
Location:
Code:
NCT05246267
Conditions
Chronic Rhinosinusitis With Nasal Polyps
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Dupilumab
Sponsor:
LifeBridge Health
Location:
Code:
NCT03472144
Conditions
Chronic Sinusitis, Ethmoidal
Chronic Sinusitis - Ethmoidal Anterior
Chronic Sinusitis
Chronic Sinusitis - Ethmoidal, Posterior
Chronic Sinusitis, Sphenoidal
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
gel loaded with steroids (momentasone)
gel loaded with antibiotic (Levofloxacin)
gel loaded with both steroids and antibiotic
Sponsor:
Sanofi
Location:
Code:
NCT06454240
Conditions
Chronic Rhinosinusitis With Nasal Polyps
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
lunsekimig
placebo
Sponsor:
Johns Hopkins University
Location:
Code:
NCT04362501
Conditions
Chronic Sinusitis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
dupilumab
placebo
Sponsor:
Johns Hopkins University
Location:
Code:
NCT05895929
Conditions
Chronic Rhinosinusitis With Nasal Polyps
Chronic Rhinosinusitis (Diagnosis)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Mepolizumab
Sponsor:
Lyra Therapeutics
Location:
Code:
NCT05295459
Conditions
Chronic Sinusitis
Chronic Rhinosinusitis (Diagnosis)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
LYR-210
Sham procedure control
Background therapy
Sponsor:
University of Florida
Location:
Code:
NCT03970655
Conditions
Chronic Rhinosinusitis (Diagnosis)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Bupivacaine or Ropivacaine with epinephrine plus dexamethasone - Group 1
Bupivacaine or Ropivacaine with epinephrine plus dexamethasone - Group 2
Sponsor:
University of South Florida
Location:
Code:
NCT04430179
Conditions
Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT]
Placebo
Sponsor:
UCLA
Location:
Code:
NCT06191640
Conditions
Cystic Fibrosis in Children
Cystic Fibrosis
Chronic Rhinosinusitis (Diagnosis)
Olfactory Disorder
Olfactory Impairment
Eligibility Criteria
Sex: All
Age: 2 - 8
Healthy Volunteers: Not accepted
Interventions
Ivacaftor or elexacaftor/tezacaftor/ivacaftor
Sponsor:
Upstream Bio Inc.
Location:
Code:
NCT06164704
Conditions
Chronic Rhinosinusitis With Nasal Polyps
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Verekitug (UPB-101)
Placebo
Sponsor:
UCLA
Location:
Code:
NCT04628442
Conditions
Chronic Rhinosinusitis (Diagnosis)
Chronic Rhinosinusitis With Nasal Polyps
Asthma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Sinonasal Debridement Procedure
Nasal Polyp Removal
Biopsy